CDTX logo

CDTX
Cidara Therapeutics Inc

8,979
Mkt Cap
$6.94B
Volume
426,432.00
52W High
$221.20
52W Low
$15.22
PE Ratio
-18.74
CDTX Fundamentals
Price
$220.80
Prev Close
$220.86
Open
$220.86
50D MA
$170.63
Beta
0.62
Avg. Volume
2.23M
EPS (Annual)
-$26.46
P/B
15.33
Rev/Employee
$33,552.63
Loading...
Loading...
News
all
press releases
Top Biotech Stocks To Add to Your Watchlist - December 20th
Amicus Therapeutics, Vertex Pharmaceuticals, Danaher, United Therapeutics, Moderna, Cidara Therapeutics, and Celcuity are the seven Biotech stocks to watch today, according to MarketBeat's stock...
MarketBeat·6d ago
News Placeholder
More News
News Placeholder
Halper Sadeh LLC Encourages MRSN, CDTX, RYI Shareholders to Contact the Firm to Discuss Their Rights
Halper Sadeh LLC Encourages MRSN, CDTX, RYI Shareholders to Contact the Firm to Discuss Their Rights Halper Sadeh LLC Encourages MRSN, CDTX, RYI Shareholders to Contact the Firm to Discuss Their...
PR Newswire·9d ago
News Placeholder
Best Biotech Stocks To Watch Now - December 16th
Vertex Pharmaceuticals, Danaher, Cidara Therapeutics, Abivax, and argenex are the five Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks are shares of...
MarketBeat·10d ago
News Placeholder
Eli Lilly or Merck: Where Should Investors Put Their Money?
LLY's explosive GLP-1 growth, deep obesity pipeline and strong estimate momentum give it the edge over MRK despite a richer valuation.
Zacks·10d ago
News Placeholder
Shane Ward Sells 9,959 Shares of Cidara Therapeutics (NASDAQ:CDTX) Stock
Cidara Therapeutics, Inc. (NASDAQ:CDTX - Get Free Report) COO Shane Ward sold 9,959 shares of the stock in a transaction dated Wednesday, December 10th. The stock was sold at an average price of...
MarketBeat·13d ago
News Placeholder
Cidara Therapeutics (NASDAQ:CDTX) COO Sells 9,959 Shares
Cidara Therapeutics, Inc. (NASDAQ:CDTX - Get Free Report) COO Shane Ward sold 9,959 shares of Cidara Therapeutics stock in a transaction dated Wednesday, December 10th. The shares were sold at an...
MarketBeat·14d ago
News Placeholder
Cidara Therapeutics, Inc. $CDTX Shares Sold by BVF Inc. IL
BVF Inc. IL cut its position in Cidara Therapeutics, Inc. (NASDAQ:CDTX - Free Report) by 15.0% during the second quarter, according to the company in its most recent 13F filing with the Securities...
MarketBeat·14d ago
News Placeholder
Cidara Therapeutics, Inc. (NASDAQ:CDTX) Receives Average Rating of "Hold" from Brokerages
Shares of Cidara Therapeutics, Inc. (NASDAQ:CDTX - Get Free Report) have received a consensus recommendation of "Hold" from the twelve research firms that are covering the stock, Marketbeat.com...
MarketBeat·14d ago
News Placeholder
Velan Capital Investment Management LP Makes New Investment in Cidara Therapeutics, Inc. $CDTX
Velan Capital Investment Management LP purchased a new position in Cidara Therapeutics, Inc. (NASDAQ:CDTX - Free Report) in the 2nd quarter, according to its most recent 13F filing with the...
MarketBeat·17d ago
News Placeholder
Stempoint Capital LP Takes Position in Cidara Therapeutics, Inc. $CDTX
Stempoint Capital LP bought a new stake in shares of Cidara Therapeutics, Inc. (NASDAQ:CDTX - Free Report) during the 2nd quarter, according to its most recent filing with the SEC. The fund bought...
MarketBeat·17d ago
<
1
2
...
>

Latest CDTX News

View

Advertisement|Remove ads.

Advertisement|Remove ads.